Biblio
“Purported Interactions of Amyloid-β and Glucocorticoids in Cytotoxicity and Genotoxicity: Implications in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1085-1094, 2016.
, “Pupillary Responses as a Biomarker of Early Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1419-1428, 2017.
, “Puerarin Ameliorates D-Galactose Induced Enhanced Hippocampal Neurogenesis and Tau Hyperphosphorylation in Rat Brain.”, J Alzheimers Dis, vol. 51, no. 2, pp. 605-17, 2016.
, “Psychotropic Polypharmacy in Patients with Dementia: Prevalence and Predictors.”, J Alzheimers Dis, vol. 56, no. 2, pp. 707-716, 2017.
, “Psychotropic Drug Prescription in Patients with Dementia: Nursing Home Residents Versus Patients Living at Home.”, J Alzheimers Dis, vol. 49, no. 3, pp. 671-80, 2016.
, “Psychotic Symptoms Associated with Poor Renal Function in Mild Cognitive Impairment and Dementias.”, J Alzheimers Dis, vol. 58, no. 1, pp. 243-252, 2017.
, “Psychosocial Risk and Protective Factors and Incident Mild Cognitive Impairment and Dementia in Community Dwelling Elderly: Findings from the Singapore Longitudinal Ageing Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 603-611, 2017.
, “Psychosis as a Treatment Target in Dementia: A Roadmap for Designing Interventions.”, J Alzheimers Dis, vol. 88, no. 4, pp. 1203-1228, 2022.
, “Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 2, pp. 677-685, 2023.
, “Psychometric Properties of the Memory Binding Test: Test-Retest Reliability and Convergent Validity.”, J Alzheimers Dis, vol. 50, no. 4, pp. 999-1010, 2016.
, “Psychometric Properties of Apathy Scales in Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1065-1082, 2018.
, “Psychological Distress, Self-Beliefs, and Risk of Cognitive Impairment and Dementia.”, J Alzheimers Dis, vol. 65, no. 3, pp. 1041-1050, 2018.
, “Psychological Distress in Caregivers for People with Dementia: A Population-Based Analysis of a National Cross-Sectional Study.”, J Alzheimers Dis, vol. 85, no. 2, pp. 667-674, 2021.
, “Psychological and Mnemonic Benefits of Nostalgia for People with Dementia.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1327-1344, 2018.
, “PSD-93 Attenuates Amyloid-β-Mediated Cognitive Dysfunction by Promoting the Catabolism of Amyloid-β.”, J Alzheimers Dis, vol. 59, no. 3, pp. 913-927, 2017.
, “A Prototype for the Voice Analysis Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 473-481, 2018.
, “Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-β Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 84, no. 1, pp. 377-392, 2021.
, “Protofibrillar and Fibrillar Amyloid-β Binding Proteins in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1053-1064, 2018.
, “Proteomics Analysis of Blood Serums from Alzheimer's Disease Patients Using iTRAQ Labeling Technology.”, J Alzheimers Dis, vol. 56, no. 1, pp. 361-378, 2017.
, “Proteomic Profiling of Mouse Brains Exposed to Blast-Induced Mild Traumatic Brain Injury Reveals Changes in Axonal Proteins and Phosphorylated Tau.”, J Alzheimers Dis, vol. 66, no. 2, pp. 751-773, 2018.
, “Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1243-1254, 2022.
, “Proteome Profiling Identified Amyloid-β Protein Precursor as a Novel Binding Partner and Modulator of VGLUT1.”, J Alzheimers Dis, vol. 81, no. 3, pp. 981-1038, 2021.
, “Proteome Network Analysis Identifies Potential Biomarkers for Brain Aging.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1767-1780, 2023.
, “Protein Phosphorylation is a Key Mechanism in Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 4, pp. 953-978, 2017.
, “Protein Misfolding in Prion and Prion-Like Diseases: Reconsidering a Required Role for Protein Loss-of-Function.”, J Alzheimers Dis, vol. 54, no. 1, pp. 3-29, 2016.
,